Ticker HubNasdaq

PEPG

PepGen Inc. Common Stock

PHARMACEUTICAL PREPARATIONSLatest premarket mover

Latest price

$6.25+161.51%

As of Nov 10, 2026, 10:20 AM EST · Market data by Massive

Market cap

$165.5M

Volume

67.1M

Previous close

$2.39

Day range

$5.15 – $6.49

Listed

May 6, 2022

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET

Five-day open $2.47Latest interval $6.21

Newsroom

Latest PEPG coverage

Nov 10, 2026

Pre-Market Movers: PEPG, SMX, MI Lead the Small-Cap Scan

PEPG led a group of 10 active small-cap stocks flagged for editorial review.

PEPGSMXMIMNDO

Recent catalyst headlines

PepGen Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights

Nov 10, 2026

PepGen Announces Positive Phase 2 FREEDOM2-DM1 10 mg/kg Results Demonstrating Highest Reported Splicing Correction and Improvements Across Multiple Functional Measures

Nov 10, 2026

PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Aug 6, 2026

Company overview

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Industry: PHARMACEUTICAL PREPARATIONS
Employees: 57
Headquarters: BOSTON, MA
CIK: 0001835597

Company website View advanced chart

SEC filings

8-K

10-Q

8-K

10-Q

4 filing

8-K

PRIMARY DOCUMENT

Browse EDGAR

Profile at a glance

May 6, 2022

Listed

Employees

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.